Resilient Industry Adapts to Challenges
SOCMA’s 2026 Contract Manufacturing Outlook shows a resilient, innovative specialty chemical sector, with SMBs driving agility amid tariffs, regulatory complexity, and global uncertainty.

The 2026 SOCMA Contract Manufacturing Outlook captures an industry that is resilient, innovative,and prepared for the challenges ahead. Nearly 70 percent of survey responses came from companies with annual revenues of $100 million or less, providing a strong perspective from the small to midsized businesses that form the backbone of the specialty chemical sector.
The operating environment continues to be defined by tariffs, trade uncertainty, regulatory complexity, and an evolving cybersecurity landscape. Across three years of survey data from 2024 through 2026, one theme emerges clearly: there is certainty in uncertainty.
The story is one of continuity and agility — this industry not only adapts as market conditions shift but uses volatility as a proving ground for resilience and leadership.
Chemistry Demand and Operational Investment Across three years of survey data, the mix of chemistries shifted dramatically, with legacy processes giving way to more specialized, value-added reactions. Polymerization, once the dominant process at nearly 60% in 2024, has fallen to just above 30% in 2026. By contrast, esterification has surged to more than 50%, making it the top-utilized chemistry, and ethoxylation has nearly doubled in demand. These movements highlight the industry’s pivot toward performance-driven and application-focused chemistries.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
Company
SOCMA Society of Chemical1850 M Street NW, Suite 700
Washington, DC 20036-5810
most read

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance
The ECA Foundation, one of the most important not-for-profit organizations for regulatory expertise in the pharmaceutical industry, aims to become the largest independent GMP/GDP organization in the world.

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.

20 Years of CHEManager International
Incredible but true: CHEManager International is celebrating its 20th anniversary!

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0









